ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Pirarubicin induces an autophagic cytoprotective response through suppression of the mammalian target of rapamycin signaling pathway in human bladder cancer cells

Li Kuiqing; Chen Xu; Liu Cheng; Gu Peng; Li Zhuohang; Wu Shaoxu; Xu Kewei; Lin Tianxin*; Huang Jian
Biochemical and Biophysical Research Communications2015-5-1DOI: 10.1016/j.bbrc.2015.03.042
7阅读
引用收藏
分享

摘要

Pirarubicin is widely used in intravesical chemotherapy for bladder cancer, but its efficacy is limited due to drug resistance; the mechanism has not been well studied. Emerging evidence shows that autophagy can be a novel target for cancer therapy. This study aimed to investigate the role of autophagy in pirarubicin-treated bladder cancer cells. Bladder cancer cells EJ and J82 were treated with pirarubicin, siRNA, 3-methyladenine or hydroxychloroquine. Cell proliferation and apoptosis were tested by cell survival assay and flow cytometric analysis, respectively. Autophagy was evaluated by immunoblotting before and after the treatments. The phosphorylated mammalian target of rapamycin, serine/threonine kinase p70 S6 kinase, and eukaryotic translation initiation factor 4E binding protein 1 were also investigated by immunoblotting. We found that pirarubicin could induce autophagy in bladder cancer cells. Inhibition of autophagy by 3-methyladenine, hydroxychloroquine or knockdown of autophagy related gene 3 significantly increased apoptosis in pirarubicin-treated bladder cancer cells. Pirarubicin-induced autophagy was mediated via the mTOR/p70S6K/4E-BP1 signaling pathway. In conclusion, autophagy induced by pirarubicin plays a cytoprotective role in bladder cancer cells, suggesting that inhibition of autophagy may improve efficacy over traditional pirarubicin chemotherapy in bladder cancer patients.

学科与关键词

关键词
Bladder cancerPirarubicinmTORAutophagyApoptosis
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Biochemical and Biophysical Research Communications
发表日期
2015-05-01
卷期
第 460 卷, 第 2 期
页码
380-385
DOI
10.1016/j.bbrc.2015.03.042
语言
ENGLISH
期刊收录
SCIE
期刊等级
Q3
成果收录
SCI
资助标注
National Natural Science Foundation of China [U1301221, 81472384, 81372729, 81272808, 81172431]; Guangdong Province Natural Scientific Foundation [S2013020012671, 07117336, 10151008901000024]; Specialized Research Fund for the Doctoral Program of Higher Education [20130171110073]; Sun Yat-Sen University Clinical Research 5010 Program [2007018, J201401]; National Clinical Key Specialty Construction Project for Department of Urology and Department of Oncology; Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes, Sun-Yat-Sen University [KLB09001]; Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology [[2013]163]

作者

  • L

    Li Kuiqing (第一作者)

  • C

    Chen Xu

查看全部 9 位作者收起作者
  • L

    Liu Cheng

  • G

    Gu Peng

  • L

    Li Zhuohang

  • W

    Wu Shaoxu

  • X

    Xu Kewei

  • L

    Lin Tianxin (通讯)

  • H

    Huang Jian

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417